Arnaud Jaccard

11PUBLICATIONS
133CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityEpidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 29, 2026
Extranodal natural killer/T-cell lymphoma: From fatal to curable.

|May 12, 2026
Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis.

|Mar 28, 2025
A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrils.

Gemma Martinez-Rivas, Maria Victoria Ayala, Sebastien Bender

|Dec 06, 2024
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm.

Sabine Khalife-Hachem, Arnaud Pages, Elie Akoury

|Apr 24, 2024
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.

Yuta Ito, Amira Marouf, Yasunori Kogure

|Dec 14, 2023
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series.

Nathalie Forgeard, Dikélélé Elessa, Alexander Carpinteiro

Pageof 2

Frequent Collaborators

3 joint publications

Efstathios Kastritis

3 joint publications

Monique Minnema

2 joint publications

Laurence de Leval

2 joint publications

Giampaolo Merlini